Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-001644-19Phase 3Completed
Phase 3, randomised trial in gestational diabetes mellitus (GDM) comparing Metformin plus usual care with Placebo plus usual care (2 arms). Primary endpoints: Composite primary efficacy outcome, Insulin requirement and 2 more. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-001644-19.